Walking away from metabolic risks: HIV study tests simple step solution
NCT ID NCT05896852
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests whether a home-based walking program can improve blood sugar, cholesterol, and body measurements in people living with HIV who also have metabolic syndrome. Fifty participants will gradually increase their walking over six months. The main goal is to see if the program is acceptable and easy to stick with, while also checking for health changes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- walking program
- What this could lead to
- If successful, this could show that a simple walking routine helps manage metabolic risks in people with HIV.
- What could go wrong
- This is a small, early feasibility study (50 participants) focused on acceptability, not proof of effectiveness. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 * Persons living with or without HIV * Metabolic Syndrome or risk factors for metabolic syndrome with BMI \>=30 * Able to provide informed consent * No physical limitations that prevent walking for more than 10 minutes * Can provide evidence of medical clearance by healthcare provider, if required before or during the study Exclusion Criteria: * Currently exercising regularly (at least 2x weekly of at least 20minutes of moderate or vigorous activity) * Current enrollment in another physician activity and/or dietary clinical trial or on diet/weight-loss program * Active plans for bariatric surgery * Inability to commit to the intervention schedule * Not eligible as per screening form * Currently pregnant or planning to become pregnant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Georgetown University
Washington D.C., District of Columbia, 20007, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cancer drug flush out hidden HIV?
- Can a weekly weight drug quiet gout attacks?
- Can two antibodies and a cancer drug free people with HIV from daily pills?
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
- Can tailoring bypass length improve weight loss surgery results?